U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H21N4O6P
Molecular Weight 468.3991
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FOSMANOGEPIX

SMILES

NC1=C(C=CC=[N+]1COP(O)([O-])=O)C2=CC(CC3=CC=C(COC4=CC=CC=N4)C=C3)=NO2

InChI

InChIKey=JQONJQKKVAHONF-UHFFFAOYSA-N
InChI=1S/C22H21N4O6P/c23-22-19(4-3-11-26(22)15-31-33(27,28)29)20-13-18(25-32-20)12-16-6-8-17(9-7-16)14-30-21-5-1-2-10-24-21/h1-11,13,23H,12,14-15H2,(H2,27,28,29)

HIDE SMILES / InChI
Molecular Formula C22H21N4O6P
Molecular Weight 468.3991
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
139594
Substance Class Chemical
Created
by admin
on Sat Dec 16 11:25:45 GMT 2023
Edited
by admin
on Sat Dec 16 11:25:45 GMT 2023
Record UNII
1XQ871489P
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FOSMANOGEPIX
INN   USAN  
Official Name English
PYRIDINIUM, 2-AMINO-1-((PHOSPHONOOXY)METHYL)-3-(3-((4-((2-PYRIDINYLOXY)METHYL)PHENYL)METHYL)-5-ISOXAZOLYL)-, INNER SALT
Systematic Name English
(2-AMINO-3-(3-((4-(2-PYRIDYLOXYMETHYL)PHENYL)METHYL)ISOXAZOL-5-YL)PYRIDIN-1-IUM-1-YL)METHYL HYDROGEN PHOSPHATE
Systematic Name English
[12-Amino-6-oxa-1(3),7(2)-dipyridina-2(5,3)-[1,2]oxazola-4(1,4)-benzenaheptaphan-11-ium-11-yl]methyl hydrogen phosphate
Systematic Name English
APX-001
Code English
FOSMANOGEPIX [USAN]
Common Name English
fosmanogepix [INN]
Common Name English
APX001
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 667318
Created by admin on Sat Dec 16 11:25:45 GMT 2023 , Edited by admin on Sat Dec 16 11:25:45 GMT 2023
FDA ORPHAN DRUG 551416
Created by admin on Sat Dec 16 11:25:45 GMT 2023 , Edited by admin on Sat Dec 16 11:25:45 GMT 2023
FDA ORPHAN DRUG 554916
Created by admin on Sat Dec 16 11:25:45 GMT 2023 , Edited by admin on Sat Dec 16 11:25:45 GMT 2023
FDA ORPHAN DRUG 538616
Created by admin on Sat Dec 16 11:25:45 GMT 2023 , Edited by admin on Sat Dec 16 11:25:45 GMT 2023
FDA ORPHAN DRUG 555016
Created by admin on Sat Dec 16 11:25:45 GMT 2023 , Edited by admin on Sat Dec 16 11:25:45 GMT 2023
Code System Code Type Description
USAN
GH-169
Created by admin on Sat Dec 16 11:25:45 GMT 2023 , Edited by admin on Sat Dec 16 11:25:45 GMT 2023
PRIMARY
FDA UNII
1XQ871489P
Created by admin on Sat Dec 16 11:25:45 GMT 2023 , Edited by admin on Sat Dec 16 11:25:45 GMT 2023
PRIMARY
NCI_THESAURUS
C155900
Created by admin on Sat Dec 16 11:25:45 GMT 2023 , Edited by admin on Sat Dec 16 11:25:45 GMT 2023
PRIMARY
DRUG BANK
DB15183
Created by admin on Sat Dec 16 11:25:45 GMT 2023 , Edited by admin on Sat Dec 16 11:25:45 GMT 2023
PRIMARY
INN
10818
Created by admin on Sat Dec 16 11:25:45 GMT 2023 , Edited by admin on Sat Dec 16 11:25:45 GMT 2023
PRIMARY
CAS
2091769-17-2
Created by admin on Sat Dec 16 11:25:45 GMT 2023 , Edited by admin on Sat Dec 16 11:25:45 GMT 2023
PRIMARY
PUBCHEM
44123754
Created by admin on Sat Dec 16 11:25:45 GMT 2023 , Edited by admin on Sat Dec 16 11:25:45 GMT 2023
PRIMARY
SMS_ID
100000183587
Created by admin on Sat Dec 16 11:25:45 GMT 2023 , Edited by admin on Sat Dec 16 11:25:45 GMT 2023
PRIMARY
Related Record Type Details
Structure of Manogepix
METABOLITE ACTIVE -> PRODRUG
Related Record Type Details
Structure of Manogepix
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966